Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: methotrexate

Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  May 1, 2010

Information on New Approvals and Medication Safety

Filed under:Drug Updates Tagged with:ApprovalsDrugsMedicationPipelineSafety

RA Therapy Can Increase Risk for Lung Disease

Kathy Holliman  |  April 1, 2010

Vigilant screening for NTM lung disease and latent tuberculosis needed

Filed under:ConditionsRheumatoid Arthritis Tagged with:Diagnostic Criterialung diseaseRARheumatoid arthritisriskTreatmenttumor necrosis factor

Coding Corner Question

From the College  |  April 1, 2010

April’s Coding Challenge

Filed under:Billing/CodingConditionsFrom the CollegeRheumatoid Arthritis Tagged with:BillingCodingCoding CornerRheumatoid arthritis

Fatal Choices: Mixing Risk with Medicine

James T. Rosenbaum, MD  |  April 1, 2010

Mixing risk with medicine

Filed under:Uncategorized Tagged with:PatientsQualityriskSafety

The Classification Challenge of Pediatric Spondylarthritis

Robert A. Colbert, MD, PhD  |  April 1, 2010

Condition often confused with other disorders

Filed under:Axial SpondyloarthritisConditionsPediatric Conditions Tagged with:Diagnostic CriteriaJuvenile idiopathic arthritisPathogenesisPediatricPediatric SpondyloarthritisTreatment

Drug Updates

Michele B. Kaufman, PharmD, BCGP  |  March 1, 2010

Information on New Approvals and Medication Safety

Filed under:Drug Updates Tagged with:ApprovalsPipelineSLESystemic lupus erythematosus

Progress Continues in Systemic Sclerosis

Daniel E. Furst, MD, Maureen D.Mayes, MD, MPH, Dinesh Khanna, MD,James R. Seibold, MD, Rajeev Saggar,MD, and Keith M. Sullivan, MD  |  March 1, 2010

Advances in genetics and potential therapies shed new light on the disease

Filed under:ConditionsSystemic Sclerosis Tagged with:Diagnostic CriteriaPathogenesisStem CellsSystemic sclerosisTreatment

Coding Corner Question

Staff  |  January 1, 2010

January’s Coding Challenge

Filed under:Billing/CodingConditionsPractice SupportRheumatoid Arthritis Tagged with:BillingCodingInfusionRheumatoid arthritis

Letters to the Editor: In Memoriam

The Rheumatologist  |  January 1, 2010

One more prescribing rule [See “Rheuminations,” September 2009, p. 6], honored mainly in the breach, in our overspending climate: don’t prescribe an expensive brand when generics are as good or better, especially Nexium (which I have never prescribed) versus omeprazole, Lipitor versus simvastatin (which now costs the VA three cents a pill), and—for rheumatologists who are writing 80% Uloric—allopurinol except for the 10% who might need Uloric.

Filed under:Drug Updates Tagged with:DrugsIn MemoriamPrescribing RulesSafety

Philadelphia Displays Many Facets of the Healthcare Debate

David S. Pisetsky, MD, PhD  |  January 1, 2010

City of Brotherly Love displays many facets of the healthcare debate

Filed under:Legislation & AdvocacyOpinionProfessional TopicsResearch RheumRheuminationsSpeak Out Rheum Tagged with:AC&RAdvocacyHealthcareHealthcare ReformLegislationPatientsResearch

  • « Previous Page
  • 1
  • …
  • 97
  • 98
  • 99
  • 100
  • 101
  • …
  • 105
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences